Home Cart Sign in  
Chemical Structure| 934828-12-3 Chemical Structure| 934828-12-3

Structure of Zabadinostat
CAS No.: 934828-12-3

Chemical Structure| 934828-12-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

HDAC-IN-4 is a histone deacetylase (HDAC) inhibitor.

Synonyms: CXD101; HDAC-IN-4; AZD 9468

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zabadinostat

CAS No. :934828-12-3
Formula : C24H29N5O
M.W : 403.52
SMILES Code : O=C(NC1=CC=CC=C1N)C2=CC=C(C3CCN(CC4=CN(C)N=C4C)CC3)C=C2
Synonyms :
CXD101; HDAC-IN-4; AZD 9468
MDL No. :MFCD30489755
InChI Key :JHDZMASHNBKTPS-UHFFFAOYSA-N
Pubchem ID :16225380

Safety of Zabadinostat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Zabadinostat

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Jurkat, CEM and Raji cells 1 µM 2 days To evaluate the effect of Zabadinostat on MHC class I protein levels, results showed increased MHC class I protein levels in Jurkat, CEM and Raji cells Commun Biol. 2023 Jan 26;6(1):102
NBE1 cells 10, 100, 1000, 2000 nM 3 days To evaluate the effect of Zabadinostat on MHC class I and II gene expression, results showed increased expression of HLA-A, -E, -DMB, -DOA, -DRA and -DRB1 genes in NBE1 cells Commun Biol. 2023 Jan 26;6(1):102
BEAS2B cells 1, 10, 100, 1000 nM 3 days To evaluate the effect of Zabadinostat on MHC class I and II gene expression, results showed increased expression of HLA-A, -C, -E, -DMB, -DOA, -DOB, -DPB1, -DRA and -DRB1 genes in BEAS2B cells Commun Biol. 2023 Jan 26;6(1):102
Bone marrow-derived dendritic cells (DCs) 1 µM 48 hours To evaluate the effect of Zabadinostat on DC maturation and MHC class II gene expression, results showed increased expression of DC maturation markers CD11c and CD86, and increased MHC class II gene expression Commun Biol. 2023 Jan 26;6(1):102

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Balb/c mice Healthy mice Oral 10 mg/kg Two cycles, each cycle 5 days on/2 days off To evaluate the effect of Zabadinostat on MHC class I and II gene expression, results showed significant increase in expression of MHC class I genes H2-D1, -K1, -M3, -Q1, -Q4 and -T3 together with elevated expression of MHC class II genes H2-Aa, -DMA, -DMB1, -DMB2 and -EB1 in lung tissue Commun Biol. 2023 Jan 26;6(1):102

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01977638 Advanced Cancer PHASE1 COMPLETED 2022-10-14 Oxford University Hospitals NH... More >>S Trust, Oxford, Oxfordshire, OX3 7LE, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.48mL

0.50mL

0.25mL

12.39mL

2.48mL

1.24mL

24.78mL

4.96mL

2.48mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories